Danaher (DHR) Tops Q2 EPS by 41c
Get Alerts DHR Hot Sheet
Revenue Growth %: +8.4%
Financial Fact:
Earnings from discontinued operations, net of income taxes: -11M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Danaher (NYSE: DHR) reported Q2 EPS of $2.46, $0.41 better than the analyst estimate of $2.05. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.72 billion.
Rainer M. Blair, President and Chief Executive Officer, stated, "Broad-based strength across the portfolio helped us deliver over 30% core revenue growth and outstanding earnings per share growth and cash flow generation. We continued to make significant growth investments during the quarter, strengthening our organic growth trajectory and enhancing our portfolio with the announcement of our pending acquisition of Aldevron."
Blair continued, "We believe the combination of our leading portfolio and DBS-driven execution differentiates Danaher today and provides a strong foundation for sustainable, long-term outperformance."
For earnings history and earnings-related data on Danaher (DHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Cosciens acquires Nualtis for up to $15M in cash deal
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share